top of page

Biopharma Daily Stock Updates - 01/08/21

Updated: Jan 13, 2021

$XBI $149.54 (+0.22%) 📈


COVID:

$BNTX (+7.15%) - An In Vitro Study Shows Pfizer-BioNTech COVID-19 Vaccine Elicits Antibodies that Neutralize SARS-CoV-2 with a Mutation Associated with Rapid Transmission


$MRNA (-2.03%) - United Kingdom Medicines and Healthcare products Regulatory Agency Authorizes Use of COVID-19 Vaccine Moderna


PIPELINE:

$NLTX (-10.96%) - Neoleukin Therapeutics Receives Clinical Hold Letter from U.S. FDA Related to CMC Assay Development for NL-201


$CMRX (+69.08) - Chimerix Acquires Oncoceutics to Expand Pipeline with Late-Stage Oncology Program


$TCRR (+7.77%) - TCR² Therapeutics Announces 2021 Strategic Priorities and Milestones


FINANCIAL:

ALDX (+21.72%) - Citigroup Maintains Buy on Aldeyra Therapeutics, Lowers Price Target to $22


$KMPH - KemPharm Announces Pricing of $50 Million Public Offering of Common Stock and Warrants and Uplisting to The Nasdaq Capital Market


$RGNX (-5.11%) - REGENXBIO Announces Pricing Of Public Offering Of Common Stock




0 comments
bottom of page